ArticleParasites & vectors2026
Efficacy of afoxolaner or a combination of afoxolaner and milbemycin oxime against fleas, ticks, lice and/or intestinal nematodes in dogs naturally infested in two urban areas in Brazil.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfestations with fleas, ticks and intestinal nematodes are commonly identified in domestic dogs and have significant veterinary and public health importances. The study described in this manuscript was conducted to verify the natural parasitism of domestic dogs in two Brazilian regions, and to confirm the efficacy of the isoxazoline afoxolaner, formulated alone (NexGard®) or in combination with the macrocyclic lactone milbemycin oxime (NexGard Spectra®), for the control of fleas and ticks, and to confirm the efficacy of the afoxolaner/milbemycin oxime (MO) combination for the control of intestinal nematodes.
methodsThis trial was conducted in Mato Grosso (MT) and Maranhão (MA) states, Center-West and Northeast region. Three hundred and forty-five (345) domestic dogs, 170 in MT and 175 in MA, infested with at least one of these parasites, were studied. Dogs were treated once and evaluated approximately two and four weeks later for ectoparasites, and two weeks later for intestinal nematodes.
resultsApproximately half (47.5%) of the dogs were infested with more than one parasite, more than one third (38.6%) with intestinal nematodes. All fleas were identified as Ctenocephalides felis, ticks as Rhipicephalus linnaei (previously defined as Rhipicephalus sanguineus s.l.) and intestinal nematodes eggs as Ancylostoma, Toxocara or Trichuris. In Maranhão, 11 dogs were also infested with the chewing louse Heterodoxus spiniger. Both products had a comparable efficacy against fleas (98.4% to 100%), ticks (96.9% to 100%) and lice (100%). The MO formulation had an efficacy of ≥ 97.8% against Ancylostoma, ≥ 94.7% against Toxocara and ≥ 97.7% against Trichuris.
conclusionsThis study demonstrated a significant parasitic abundance in domestic dogs in two urban areas in Brazil, and confirmed a high efficacy of afoxolaner against fleas, ticks and lice and a high efficacy of MO against intestinal nematodes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.